Dr. Wesley Abplanalp is an American physiologist and basic scientist working on cardiovascular inflammation and regeneration. He is part of the research group of DZHK board member Prof. Stefanie Dimmeler at the Institute of Cardiovascular Regeneration at the Goethe-University...

Read more

How can older patients suffering from multiple chronic diseases be better cared for? A clinical trial is testing a new treatment approach in patients with chronic heart failure, psychological distress, and at least two other concomitant physical illnesses. Especially when mental...

Read more

The inner surface of blood vessels is lined by a wafer-thin layer of cells known as the endothelium, which forms a crucial barrier between blood and the surrounding tissue. The single-layered cell structure promotes the exchange of oxygen and nutrients, while simultaneously...

Read more

Revacept is a novel platelet inhibitor that binds specifically to injured blood vessels and can be used safely during catheter interventions. This is now demonstrated in a study enrolling patients with narrowed coronary arteries co-funded by the German Centre for Cardiovascular...

Read more

Those who need to change their eating habits to normalise their blood pressure should start with a fast. A research group led by DZHK scientists Dr Sofia Forslund and Prof. Dominik N. Müller has investigated why patients can use it as a tool to improve their health in the long...

Read more

Recovering from a corona infection at home - that's what most people want to do. But sometimes hospitalization is unavoidable. But when is the right time for this? This is being investigated by the COVID SMART study at LMU Klinikum München. Anyone who has risk factors for a...

Read more

In the newly inaugurated Käthe-Beutler-Haus, research teams in vascular biomedicine from the Berlin Institute of Health (BIH) at Charité and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) will work under one roof in the future. The MDC is a...

Read more

The Lead Discovery Center GmbH (LDC), Novo Nordisk and Heidelberg University Hospital are starting a collaboration to develop new therapy for heart failure.

Read more

A team of researchers led by Prof. Wolfram Ruf, Principal Investigator at the DZHK and Scientific Director of the Center for Thrombosis and Hemostasis (CTH) at the University Medical Center Mainz, has uncovered the mechanism that triggers the autoimmune disease APS...

Read more

A research group from the German Center for Cardiovascular Research (DZHK) at the University Medical Center Hamburg-Eppendorf (UKE) is growing artificial heart tissue to heal heart failure. The researchers can now use cells with sophisticated properties for this purpose. This is...

Read more